Logo Logo
Eine Ebene nach oben
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Springe zu: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2013 | 2011 | 2009 | 2008
Anzahl der Publikationen: 35

2022

Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Garke, Madlen; Christgen, Matthias; Kates, Ronald; Grischke, Eva Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Wuerstlein, Rachel; Graeser, Monika; Nitz, Ulrike; Kreipe, Hans; Gluz, Oleg und Harbeck, Nadia (2022): Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial. In: Breast Cancer Research, Bd. 24, Nr. 1, 58

Ditsch, Nina; Woecke, Achim; Untch, Michael; Jackisch, Christian; Albert, Ute-Susann; Banys-Paluchowski, Maggie; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fallenberg, Eva Maria; Fasching, Peter A.; Fehm, Tanja N.; Friedrich, Michael; Gerber, Bernd; Gluz, Oleg; Harbeck, Nadia; Heil, Jörg; Huober, Jens; Kreipe, Hans H.; Krug, David; Kuehn, Thorsten; Kuemmel, Sherko; Kolberg-Liedtke, Cornelia; Loibl, Sibylle; Lueftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung-Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Witzel, Isabell; Mueller, Volkmar; Janni, Wolfgang und Thill, Marc (2022): AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022. In: Breast Care, Bd. 17, Nr. 4: S. 403-420

Thill, Marc; Lueftner, Diana; Kolberg-Liedtke, Cornelia; Albert, Ute-Susann; Banys-Paluchowski, Maggie; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fallenberg, Eva Maria; Fasching, Peter A.; Fehm, Tanja; Friedrich, Michael; Gerber, Bernd; Gluz, Oleg; Harbeck, Nadia; Heil, Joerg; Huober, Jens; Jackisch, Christian; Kreipe, Hans-Heinrich; Krug, David; Kuehn, Thorsten; Kuemmel, Sherko; Loibl, Sibylle; Lux, Michael; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung-Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Witzel, Isabell; Woeckel, Achim; Mueller, Volkmar; Janni, Wolfgang und Ditsch, Nina (2022): AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022. In: Breast Care, Bd. 17, Nr. 4: S. 421-429

Gluz, Oleg; Nitz, Ulrike; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Kuemmel, Sherko; Mohammadian, Mohammad Parsa; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Graeser, Monika; Pelz, Enrico; Jozwiak, Katarzyna; Zu Eulenburg, Christine; Kreipe, Hans Heinrich und Harbeck, Nadia (2022): De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial. In: Clinical Cancer Research, Bd. 28, Nr. 22: S. 4995-5003

Banys-Paluchowski, Maggie; Thill, Marc; Kuhn, Thorsten; Ditsch, Nina; Heil, Jörg; Woeckel, Achim; Fallenberg, Eva; Friedrich, Michael; Kuemmel, Sherko; Mueller, Volkmar; Janni, Wolfgang; Albert, Ute-Susann; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fasching, Peter; Fehm, Tanja; Gluz, Oleg; Harbeck, Nadia; Huober, Jens; Jackisch, Christian; Kolberg-Liedtke, Cornelia; Kreipe, Hans H.; Krug, David; Loibl, Sibylle; Lueftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, H. Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Witzel, Isabell und Gerber, Bernd (2022): AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022. In: Geburtshilfe und Frauenheilkunde, Bd. 82, Nr. 10: S. 1031-1043

de Gregorio, Amelie; Janni, Wolfgang; Friedl, Thomas W. P.; Nitz, Ulrike; Rack, Brigitte; Schneeweiss, Andreas; Kates, Ronald; Fehm, Tanja; Kreipe, Hans; Christgen, Matthias; Kuemmel, Sherko; Trapp, Elisabeth; Wuerstlein, Rachel; Haertkopf, Andreas; Clemens, Michael; Reimer, Toralf; Haeberle, Lothar; Fasching, Peter A.; Gluz, Oleg und Harbeck, Nadia (2022): The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C. In: British Journal of Cancer, Bd. 126, Nr. 12: S. 1715-1724

Grote, Isabel; Bartels, Stephan; Christgen, Henriette; Radner, Martin; Gronewold, Malte; Kandt, Leonie; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Graeser, Monika; Kuemmel, Sherko; Nitz, Ulrike; Harbeck, Nadia; Kreipe, Hans und Christgen, Matthias (2022): ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer. In: Modern Pathology, Bd. 35, Nr. 12: S. 1804-1811

Nitz, Ulrike; Gluz, Oleg; Graeser, Monika; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Braun, Michael; Augustin, Doris; Potenberg, Jochem; Krauss, Katja; Schumacher, Claudia; Forstbauer, Helmut; Reimer, Toralf; Stefek, Andrea; Fischer, Hans Holger; Pelz, Enrico; Eulenburg, Christine zu; Kates, Ronald; Würstlein, Rachel; Kreipe, Hans Heinrich und Harbeck, Nadia (2022): De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial. In: Lancet Oncology, Bd. 23, Nr. 5: S. 625-635

2021

Wuerstlein, Rachel; Harbeck, Nadia; Grischke, Eva-Maria; Forstmeyer, Dirk; Schumann, Raquel von; Krabisch, Petra; Ludtke-Heckenkamp, Kerstin; Stefek, Andrea; Stoetzer, Oliver; Grafe, Andrea; Kaltenecker, Gabriele; Forstbauer, Helmut; Augustin, Doris; Schrader, Iris; Tio, Joke; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E. und Graeser, Monika Karla (2021): Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients. In: Breast Care, Bd. 16, Nr. 1: S. 50-58

Christgen, Matthias; Kandt, Leonie Donata; Antonopoulos, Wiebke; Bartels, Stephan; Bockstal, Mieke R. van; Bredt, Martin; Brito, Maria Jose; Christgen, Henriette; Colpaert, Cecile; Cserni, Balint; Cserni, Gabor; Daemmrich, Maximilian E.; Danebrock, Raihanatou; Dedeurwaerdere, Franceska; Deurzen, Carolien H. M. van; Erber, Ramona; Fathke, Christine; Feist, Henning; Fiche, Maryse; Gonzalez, Claudia Aura; Hoeve, Natalie D. ter; Kooreman, Loes; Krech, Till; Kristiansen, Glen; Kulka, Janina; Laenger, Florian; Lafos, Marcel; Lehmann, Ulrich; Martin-Martinez, Maria Dolores; Mueller, Sophie; Pelz, Enrico; Raap, Mieke; Ravarino, Alberto; Reineke-Plaass, Tanja; Schaumann, Nora; Schelfhout, Anne-Marie; Schepper, Maxim de; Schlue, Jerome; Vijver, Koen van de; Waelput, Wim; Wellmann, Axel; Graeser, Monika; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Harbeck, Nadia; Desmedt, Christine; Floris, Giuseppe; Derksen, Patrick W. B.; Diest, Paul J. van; Vincent-Salomon, Anne und Kreipe, Hans (2021): Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma. In: Journal of Pathology Clinical Research, Bd. 8, Nr. 2: S. 191-205

Graeser, Monika; Feuerhake, Friedrich; Gluz, Oleg; Volk, Valery; Hauptmann, Michael; Jozwiak, Katarzyna; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kolberg-Liedtke, Cornelia; Kates, Ronald; Wuerstlein, Rachel; Nitz, Ulrike; Kreipe, Hans Heinrich und Harbeck, Nadia (2021): Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial. In: Journal for Immunotherapy of Cancer, Bd. 9, Nr. 5, e002198

Graeser, Monika; Harbeck, Nadia; Gluz, Oleg; Wuerstlein, Rachel; Eulenburg, Christine zu; Schumacher, Claudia; Grischke, Eva -Maria; Forstbauer, Helmut; Dimpfl, Moritz; Braun, Michael; Christgen, Matthias; Kreipe, Hans Heinrich; Potenberg, Jochem; Schumann, Raquel von; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Kuemmel, Sherko und Nitz, Ulrike (2021): The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials. In: Breast, Bd. 59: S. 58-66

Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Herzog, Christopher; Umutlu, Lale; Frydrychowicz, Alex; Rjosk-Dendorfer, Dorothea; Wuerstlein, Rachel; Culemann, Ralph; Eulenburg, Christine; Adams, Jascha; Nitzsche, Henrik; Prange, Anna; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Potenberg, Jochem; Schumann, Raquel von; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K. und Nitz, Ulrike (2021): Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials. In: Breast Cancer Research, Bd. 23, Nr. 1, 36

Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Wuerstlein, Rachel; Kuemmel, Sherko; Schumacher, Claudia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Christgen, Matthias; Adams, Jascha; Nitzsche, Henrik; Just, Marianne; Fischer, Hans Holger; Aktas, Bahriye; Potenberg, Jochem; Schumann, Raquel von; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K. und Nitz, Ulrike (2021): Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials. In: International Journal of Cancer, Bd. 148, Nr. 10: S. 2614-2627

Grote, Isabel; Bartels, Stephan; Kandt, Leonie; Bollmann, Laura; Christgen, Henriette; Gronewold, Malte; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Nitz, Ulrike; Kuemmel, Sherko; Zu Eulenburg, Christine; Braun, Michael; Aktas, Bahriye; Grischke, Eva-Maria; Schumacher, Claudia; Luedtke-Heckenkamp, Kerstin; Kates, Ronald; Wuerstlein, Rachel; Graeser, Monika; Harbeck, Nadia; Christgen, Matthias und Kreipe, Hans (2021): TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer. In: Cancer Medicine, Bd. 10, Nr. 23: S. 8581-8594

2020

Kolberg-Liedtke, Cornelia; Würstlein, Rachel; Gluz, Oleg; Heitz, Florian; Freudenberger, Muriel; Bensmann, Elena; du Bois, Andreas; Nitz, Ulrike; Pelz, Enrico; Warm, Matthias; Ortmann, Monika; Sultova, Elena; Brucker, Sara Y.; Kates, Ronald E.; Fehm, Tanja und Harbeck, Nadia (2020): Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet. In: Breast Care

Kolberg-Liedtke, Cornelia; Gluz, Oleg; Heinisch, Fred; Feuerhake, Friedrich; Kreipe, Hans; Clemens; Nuding, Benno; Malter, Wolfram; Reimer, Tora; Würstlein, Rachel; Graeser, Monika; Shak, Steve; Nitz, Ulrike; Kates, Ronald; Christgen, Matthias und Harbeck, Nadia (2020): Association of TILs with clinical parameters, Recurrence Score (R) results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial. In: Breast Cancer Research, Bd. 22, Nr. 1, 47

Nitz, Ulrike; Gluz, Oleg; Kreipe, Hans H.; Christgen, Matthias; Kuemmel, Sherko; Baehner, Frederick L.; Shak, Steven; Aktas, Bahriye; Braun, Michael; Ludtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Nuding, Benno; Darsow, Maren; Schumacher, Claudia; Krauss, Katja; Malter, Wolfram; Thill, Marc; Warm, Mathias; Würstlein, Rachel; Kates, Ronald E. und Harbeck, Nadia (2020): The run-in phase of the prospective WSG-ADAPT HR+/HER2-trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer. In: Therapeutic Advances in Medical Oncology, Bd. 12: S. 1-9 [PDF, 531kB]

Dowsett, Mitch; Ellis, Matthew J. ORCID logoORCID: https://orcid.org/0000-0002-8467-8534; Dixon, J. Michael; Gluz, Oleg; Robertson, John; Kates, Ronald; Suman, Vera J.; Turnbull, Arran K.; Nitz, Ulrike; Christgen, Matthias; Kreipe, Hans; Kuemmel, Sherko; Bliss, Judith M.; Barry, Peter; Johnston, Stephen R.; Jacobs, Samuel A.; Ma, Cynthia X.; Smith, Ian E. und Harbeck, Nadia ORCID logoORCID: https://orcid.org/0000-0002-9744-7372 (2020): Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic. In: Npj Breast Cancer, Bd. 6, Nr. 1, 21: S. 1-10 [PDF, 1MB]

Gluz, Oleg; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Würstlein, Rachel; Pelz, Enrico; Nitz, Ulrike; Kreipe, Hans Heinrich und Harbeck, Nadia (2020): Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial. In: International Journal of Cancer, Bd. 146, Nr. 1: S. 262-271

Christgen, Matthias; Gluz, Oleg; Harbeck, Nadia; Kates, Ronald E.; Raap, Mieke; Christgen, Henriette; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Stefek, Andrea; Krabisch, Petra; Just, Marianne; Augustin, Doris; Graeser, Monika; Baehner, Frederick; Würstlein, Rachel; Nitz, Ulrike und Kreipe, Hans (2020): Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer. In: Cancer, Bd. 126, Nr. 22: S. 4847-4858

2019

Nitz, Ulrike; Gluz, Oleg; Clemens, Michael; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Aktas, Bahriye; Stefek, Andrea; Pollmanns, Anke; Lorenz-Salehi, Fatemeh; Uleer, Christoph; Krabisch, Petra; Kümmel, Sherko; Liedtke, Cornelia; Shak, Steven; Wuerstlein, Rachel; Christgen, Matthias; Kates, Ronald E.; Kreipe, Hans H.; Harbeck, Nadia; Ackermann, S.; Aktas, B.; Augustin, D.; Baake, G.; Baumann, K.; Berger, R.; Bettscheider, J.; Bischoff, J.; Clemens, M.; Deryal, M.; Dubbers, H.; Duchting, D.; Dunnebacke, J.; Fett, W.; Fietz, T.; Fischer, H.; Forner, M.; Forstbauer, H.; Freese, K.; Geberth, M.; Glados, M.; Gnauert, K.; Goette, O.; Gohring, U.; Goppinger, A.; Grafe, A.; Hackenberg, R.; Hackmann, J.; Hellriegel, M.; Heyl, V.; Hoestermann, C.; Hoffmann, G.; Hofmann, M.; Hucke, J.; Jackisch, C.; Jungberg, P.; Just, M.; Kahl, C.; Klare, P.; Kogel, M.; Kohls, A.; Amrawy, B. Konigs-El; Konnecke, P.; Krabisch, P.; Kraudelt, S.; Kremers, S.; Kummel, S.; Kurbacher, C.; Kusche, J.; Liedtke, B.; Liedtke, C.; Link, H.; Lorenz, R.; Salehi, F. Lorenz; Lubbe, K.; Malter, W.; Melekian, B.; Mobus, V.; Montenarh, M.; Müller, V.; Mundhenke, C.; Niederle, N.; Nitz, U.; Noesselt, T.; Oberhoff, C.; Paas, L.; Paepke, S.; Pollmanns, A.; Reichert, D.; Reimer, T.; Romann, D.; Ruhland, T.; Runde, V.; Salem, M.; Schlosser, A.; Schneider, A.; Schrader, I.; Schulz, H.; Schumacher, C.; Schwickerath, J.; Soling, U.; Stauder, H.; Stefek, A.; Steinmetz, T.; Stickeler, E.; Terhaag, J.; Thomssen, C.; Tome, O.; Uleer, C.; Warm, M.; Wachsmann, G.; Wacker, J.; Wiebringhaus, H.; Wiest, W.; Wolfgarten, M.; Nitz, U.; Christgen, H.; Kreipe, H.; Buehne, C.; Gluz, O.; Hansen, K.; Hofmann, D.; Kates, R.; Mangold, M.; Mathissen, M.; Raeth, P.; Renner, I.; Reiser, I.; Schumacher, J.; Staedele, M. und Walter-Kirst, R. (2019): West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer. In: Journal of Clinical Oncology, Bd. 37, Nr. 10

Christgen, Matthias; Bartels, Stephan; Radner, Martin; Raap, Mieke; Rieger, Luisa; Christgen, Henriette; Gluz, Oleg; Nitz, Ulrike; Harbeck, Nadia; Lehmann, Ulrich und Kreipe, Hans (2019): ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling. In: Genes Chromosomes & Cancer, Bd. 58, Nr. 3: S. 175-185

Thill, Marc; Jackisch, Christian; Janni, Wolfgang; Müller, Volkmar; Albert, Ute-Susann; Bauerfeind, Ingo; Blohmer, Jens; Budach, Wilfried; Dall, Peter; Diel, Ingo; Fasching, Peter A.; Fehm, Tanja; Friedrich, Michael; Gerber, Bernd; Hanf, Volker; Harbeck, Nadia; Huober, Jens; Kolberg-Liedtke, Cornelia; Kreipe, Hans-Heinrich; Krug, David; Kühn, Thorsten; Kümmel, Sherko; Loibl, Sibylle; Lueftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Moebus, Volker; Müller-Schimpfle, Markus; Mundhenke, Christoph; Nitz, Ulrike; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Wenz, Frederik; Witzel, Isabell; Woeckel, Achim und Ditsch, Nina (2019): AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019. In: Breast Care, Bd. 14, Nr. 4: S. 247-255

Ditsch, Nina; Untch, Michael; Thill, Marc; Müller, Volkmar; Janni, Wolfgang; Albert, Ute-Susann; Bauerfeind, Ingo; Blohmer, Jens; Budach, Wilfried; Dall, Peter; Diel, Ingo; Fasching, Peter A.; Fehm, Tanja; Friedrich, Michael; Gerber, Bernd; Hanf, Volker; Harbeck, Nadia; Huober, Jens; Jackisch, Christian; Kolberg-Liedtke, Cornelia; Kreipe, Hans-Heinrich; Krug, David; Kühn, Thorsten; Kümmel, Sherko; Loibl, Sibylle; Lueftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Moebus, Volker; Müller-Schimpfle, Markus; Mundhenke, Christoph; Nitz, Ulrike; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Wenz, Frederik; Witzel, Isabell und Woeckel, Achim (2019): AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019. In: Breast Care, Bd. 14, Nr. 4: S. 224-245

2018

Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kuemmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; Schumann, Raquel von und Harbeck, Nadia (2018): Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results. In: Jnci-Journal of the National Cancer Institute, Bd. 110, Nr. 6, djx258: S. 628-637

Raap, Mieke; Gronewold, Malte; Christgen, Henriette; Glage, Silke; Bentires-Alj, Mohammad; Koren, Shany; Derksen, Patrick W.; Bölens, Mirjam; Jonkers, Jos; Lehmann, Ulrich; Feuerhake, Friedrich; Kühnle, Elna; Gluz, Oleg; Kates, Ronald; Nitz, Ulrike; Harbeck, Nadia; Kreipe, Hans H. und Christgen, Matthias (2018): Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2 beta. In: Laboratory Investigation, Bd. 98, Nr. 1: S. 117-129

2017

Nitz, Ulrike; Gluz, Oleg; Christgen, Matthias; Kates, Ronald E.; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kümmel, Sherko; Reimer, Toralf; Stefek, Andrea; Lorenz-Salehi, Fatemeh; Krabisch, Petra; Just, Marianne; Augustin, Doris; Liedtke, Cornelia; Chao, Calvin; Shak, Steven; Würstlein, Rachel; Kreipe, Hans H. und Harbeck, Nadia (2017): Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial. In: Breast Cancer Research and Treatment, Bd. 165, Nr. 3: S. 573-583

2016

Schouten, Philip C.; Gluz, Oleg; Harbeck, Nadia; Mohrmann, Svjetlana; Diallo-Danebrock, Raihana; Pelz, Enrico; Kruizinga, Janneke; Velds, Arno; Nieuwland, Marja; Kerkhoven, Ron M.; Liedtke, Cornelia; Frick, Markus; Kates, Ronald; Linn, Sabine C.; Nitz, Ulrike und Marme, Frederik (2016): BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial. In: International Journal of Cancer, Bd. 139, Nr. 4: S. 882-889

2013

Hofmann, Daniel; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E.; Schinkoethe, Timo; Staib, Peter und Harbeck, Nadia (2013): WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial. In: Trials 14:261 [PDF, 1MB]

Harbeck, Nadia; Blettner, Maria; Hadji, Peyman; Jackisch, Christian; Lueck, Hans-Joachim; Windemuth-Kieselbach, Christine; Zaun, Silke; Haidinger, Renate; Schmitt, Doris; Schulte, Hilde; Nitz, Ulrike und Kreienberg, Rolf (2013): Patient’s Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer. In: Breast Care, Nr. 2: S. 110-120 [PDF, 681kB]

Gluz, Oleg; Hofmann, Daniel; Würstlein, Rachel; Liedtke, Cornelia; Nitz, Ulrike und Harbeck, Nadia (2013): Genomic Profiling in Luminal Breast Cancer. In: Breast Care, Nr. 6: S. 414-422 [PDF, 261kB]

2011

Untch, Michael; Gerber, Bernd; Möbus, Volker; Schneeweiss, Andreas; Thomssen, Christoph; Minckwitz, Gunter von; Beckmann, Matthias W.; Blohmer, Jens-Uwe; Costa, Serban-Dan; Diedrich, Klaus; Diel, Ingo; Eiermann, Wolfgang; Friese, Klaus; Harbeck, Nadia; Hilfrich, Jörn; Jackisch, Christian; Janni, Wolfgang; Jänicke, Fritz; Jonat, Walter; Kaufmann, Manfred; Kiechle, Marion; Köhler, Uwe; Kreienberg, Rolf; Maass, Nicolai; Marschner, Norbert; Nitz, Ulrike; Scharl, Anton und Wallwiener, Diethelm (2011): Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011). In: Breast Care, Nr. 2: S. 144-152 [PDF, 304kB]

2009

Beckmann, Matthias W.; Blohmer, Jens-Uwe; Costa, Serban-Dan; Diedrich, Klaus; Diel, Ingo; Eiermann, Wolfgang; Friese, Klaus; Gerber, Bernd; Harbeck, Nadia; Hilfrich, Joern; Janni, Wolfgang; Jaenicke, Fritz; Jonat, Walter; Kaufmann, Manfred; Kiechle, Marion; Koehler, Uwe; Kreienberg, Rolf; Minckwitz, Gunter von; Moebus, Volker; Nitz, Ulrike; Schneeweiss, Andreas; Thomssen, Christoph und Wallwiener, Diethelm (2009): Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer). In: Breast Care, Nr. 2: S. 109-116 [PDF, 128kB]

2008

Janni, Wolfgang; Minckwitz, Gunter von; Möbus, Volker und Nitz, Ulrike (2008): Adjuvant and neoadjuvant therapy with lapatinib in ErbB2-overexpressing breast cancer. In: Breast Care, Nr. 1: S. 17-20 [PDF, 161kB]

Diese Liste wurde am Sat Apr 13 20:52:43 2024 CEST erstellt.